CTLA4 and breast cancer: There was also a significant reduction of CTLA-4+ T cells in the blood (% [p = 0.017], AbNs [p = 0.001]) and breast cancers (stromal [p = 0.029]) following 8 cycles of NAC in the same cohort of 16 patients.